← Back to headlines
Novartis Returns to Sales Growth in Q2
Novartis reported a return to sales growth in its second quarter, as the performance of newer medicines successfully offset pressure from generic competition.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
